Market Closed -
Bombay S.E.
06:00:53 2024-07-16 am EDT
|
5-day change
|
1st Jan Change
|
1,148
INR
|
+2.65%
|
|
-0.38%
|
+60.83%
|
Fiscal Period: March |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
57,812
|
-
|
-
|
Enterprise Value (EV)
1 |
51,673
|
56,164
|
55,765
|
P/E ratio
|
72.1
x
|
38.6
x
|
27.6
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.47
x
|
5.62
x
|
3.9
x
|
EV / Revenue
|
6.31
x
|
5.46
x
|
3.76
x
|
EV / EBITDA
|
46.7
x
|
32.7
x
|
22.3
x
|
EV / FCF
|
84.5
x
|
-82.1
x
|
-29.7
x
|
FCF Yield
|
1.18%
|
-1.22%
|
-3.37%
|
Price to Book
|
4.53
x
|
4.39
x
|
4.09
x
|
Nbr of stocks (in thousands)
|
50,719
|
-
|
-
|
Reference price
2 |
1,140
|
1,140
|
1,140
|
Announcement Date
|
5/23/24
|
-
|
-
|
Fiscal Period: March |
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
8,194
|
10,284
|
14,842
|
EBITDA
1 |
-
|
1,107
|
1,715
|
2,499
|
EBIT
1 |
-
|
774.4
|
1,298
|
1,950
|
Operating Margin
|
-
|
9.45%
|
12.63%
|
13.14%
|
Earnings before Tax (EBT)
1 |
-
|
919.5
|
1,491
|
2,235
|
Net income
1 |
463.2
|
921.7
|
1,486
|
2,172
|
Net margin
|
-
|
11.25%
|
14.45%
|
14.63%
|
EPS
2 |
-
|
14.49
|
29.50
|
41.23
|
Free Cash Flow
1 |
-
|
611.8
|
-684.5
|
-1,880
|
FCF margin
|
-
|
7.47%
|
-6.66%
|
-12.67%
|
FCF Conversion (EBITDA)
|
-
|
55.28%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
66.38%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/10/23
|
5/23/24
|
-
|
-
|
Fiscal Period: March |
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
2,098
|
2,524
|
2,260
|
EBITDA
1 |
265.5
|
404
|
318.5
|
EBIT
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
Net income
1 |
201
|
-
|
349
|
Net margin
|
9.58%
|
-
|
15.45%
|
EPS
2 |
4.000
|
-
|
6.900
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: March |
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,321
|
1,648
|
2,047
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
612
|
-685
|
-1,881
|
ROE (net income / shareholders' equity)
|
-
|
9.92%
|
11.7%
|
14.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
231.0
|
260.0
|
279.0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
648
|
2,723
|
4,378
|
Capex / Sales
|
-
|
7.91%
|
26.48%
|
29.5%
|
Announcement Date
|
5/10/23
|
5/23/24
|
-
|
-
|
Last Close Price
1,140
INR Average target price
1,252
INR Spread / Average Target +9.87% Consensus |
1st Jan change
|
Capi.
|
---|
| +61.53% | 856B | | +38.95% | 631B | | -3.66% | 359B | | +15.06% | 325B | | +9.18% | 297B | | +5.89% | 234B | | +16.53% | 226B | | +15.67% | 177B | | +2.47% | 165B |
Other Pharmaceuticals
|